The Provincial Infectious Diseases Advisory Committee on Infection, Prevention and Control (PIDAC-IPC) has updated the Evidence Review and Revised Recommendations for the Control of Vancomycin-Resistant Enterococci (VRE). The document was updated to capture recent research on the impact of VRE control in health care settings. Recommendations include:
1. screening, on admission, for risk factors and testing for VRE if risk factors are present.
2. using Contact Precautions for those who test positive for VRE as outlined in Annex A: Screening, Testing and Surveillance for Antibiotic-Resistant Organisms (AROs) annexed to: Routine Practices and Additional Precautions in All Health Care Settings.
An Executive Summary is also available.
For more information on VRE visit the PHO website , contact your Regional IPAC Support team or email email@example.com.